Tonix Pharmaceuticals Holding Stock Price History
TNXP Stock | USD 0.19 0.01 5.00% |
Below is the normalized historical share price chart for Tonix Pharmaceuticals Holding extending back to February 03, 2012. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Tonix Pharmaceuticals stands at 0.19, as last reported on the 1st of December, with the highest price reaching 0.21 and the lowest price hitting 0.19 during the day.
If you're considering investing in Tonix Stock, it is important to understand the factors that can impact its price. Tonix Pharmaceuticals appears to be dangerous, given 3 months investment horizon. Tonix Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.058, which indicates the firm had a 0.058% return per unit of risk over the last 3 months. We have found twenty-four technical indicators for Tonix Pharmaceuticals Holding, which you can use to evaluate the volatility of the company. Please review Tonix Pharmaceuticals' Variance of 64.35, coefficient of variation of (2,156), and Risk Adjusted Performance of (0.03) to confirm if our risk estimates are consistent with your expectations.
At this time, Tonix Pharmaceuticals' Common Stock Total Equity is relatively stable compared to the past year. As of 12/01/2024, Common Stock Shares Outstanding is likely to grow to about 559.1 K, though Sale Purchase Of Stock is likely to grow to (13.3 M). . At this time, Tonix Pharmaceuticals' Price Book Value Ratio is relatively stable compared to the past year. As of 12/01/2024, Price To Book Ratio is likely to grow to 0.07, while Price Earnings To Growth Ratio is likely to drop 0.0008. Tonix Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 10th of May 2012 | 200 Day MA 3.2541 | 50 Day MA 0.1546 | Beta 2.077 |
Tonix |
Sharpe Ratio = 0.058
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | TNXP | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
7.12 actual daily | 63 63% of assets are less volatile |
Expected Return
0.41 actual daily | 8 92% of assets have higher returns |
Risk-Adjusted Return
0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Tonix Pharmaceuticals is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Tonix Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 0.4777 | Enterprise Value Ebitda 0.9408 | Price Sales 2.8459 | Shares Float 22 M | Wall Street Target Price 21 |
Tonix Pharmaceuticals Stock Price History Chart
There are several ways to analyze Tonix Stock price data. The simplest method is using a basic Tonix candlestick price chart, which shows Tonix Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | November 21, 2024 | 0.2 |
Lowest Price | September 23, 2024 | 0.13 |
Tonix Pharmaceuticals December 1, 2024 Stock Price Synopsis
Various analyses of Tonix Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Tonix Stock. It can be used to describe the percentage change in the price of Tonix Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Tonix Stock.Tonix Pharmaceuticals Price Action Indicator | (0.01) | |
Tonix Pharmaceuticals Price Rate Of Daily Change | 0.95 | |
Tonix Pharmaceuticals Price Daily Balance Of Power | (0.50) |
Tonix Pharmaceuticals December 1, 2024 Stock Price Analysis
Tonix Stock Price History Data
The price series of Tonix Pharmaceuticals for the period between Mon, Sep 2, 2024 and Sun, Dec 1, 2024 has a statistical range of 0.17 with a coefficient of variation of 18.9. The price distribution for the period has arithmetic mean of 0.16. The median price for the last 90 days is 0.15. The company completed stock split (1:32) on 10th of June 2024. Tonix Pharmaceuticals had dividends distributed to its stock-holders on 2019-11-01.Open | High | Low | Close | Volume | ||
12/01/2024 | 0.19 | 0.21 | 0.19 | 0.19 | ||
11/29/2024 | 0.19 | 0.21 | 0.19 | 0.19 | 28,999,215 | |
11/27/2024 | 0.19 | 0.20 | 0.18 | 0.19 | 21,323,714 | |
11/26/2024 | 0.19 | 0.20 | 0.18 | 0.19 | 23,868,438 | |
11/25/2024 | 0.19 | 0.21 | 0.19 | 0.19 | 46,745,319 | |
11/22/2024 | 0.20 | 0.21 | 0.19 | 0.19 | 29,134,928 | |
11/21/2024 | 0.17 | 0.21 | 0.17 | 0.20 | 75,743,365 | |
11/20/2024 | 0.26 | 0.28 | 0.18 | 0.19 | 661,436,189 | |
11/19/2024 | 0.13 | 0.16 | 0.13 | 0.16 | 90,373,459 | |
11/18/2024 | 0.13 | 0.13 | 0.13 | 0.13 | 9,053,264 | |
11/15/2024 | 0.14 | 0.14 | 0.13 | 0.13 | 10,457,738 | |
11/14/2024 | 0.14 | 0.14 | 0.14 | 0.14 | 11,229,025 | |
11/13/2024 | 0.15 | 0.15 | 0.14 | 0.14 | 14,463,488 | |
11/12/2024 | 0.14 | 0.15 | 0.14 | 0.14 | 16,367,432 | |
11/11/2024 | 0.15 | 0.15 | 0.14 | 0.14 | 7,410,271 | |
11/08/2024 | 0.14 | 0.14 | 0.13 | 0.14 | 6,761,760 | |
11/07/2024 | 0.14 | 0.15 | 0.14 | 0.14 | 9,574,740 | |
11/06/2024 | 0.14 | 0.14 | 0.13 | 0.14 | 10,092,290 | |
11/05/2024 | 0.14 | 0.14 | 0.14 | 0.14 | 11,610,691 | |
11/04/2024 | 0.15 | 0.15 | 0.14 | 0.14 | 14,580,934 | |
11/01/2024 | 0.15 | 0.15 | 0.14 | 0.14 | 11,707,505 | |
10/31/2024 | 0.15 | 0.16 | 0.14 | 0.15 | 14,550,565 | |
10/30/2024 | 0.17 | 0.18 | 0.15 | 0.15 | 14,492,718 | |
10/29/2024 | 0.17 | 0.18 | 0.16 | 0.17 | 11,800,417 | |
10/28/2024 | 0.17 | 0.18 | 0.17 | 0.18 | 16,114,042 | |
10/25/2024 | 0.16 | 0.17 | 0.16 | 0.17 | 10,444,628 | |
10/24/2024 | 0.17 | 0.17 | 0.16 | 0.16 | 12,045,645 | |
10/23/2024 | 0.18 | 0.18 | 0.16 | 0.17 | 15,159,120 | |
10/22/2024 | 0.19 | 0.19 | 0.18 | 0.18 | 20,070,756 | |
10/21/2024 | 0.18 | 0.20 | 0.18 | 0.19 | 35,804,425 | |
10/18/2024 | 0.19 | 0.19 | 0.16 | 0.18 | 32,006,457 | |
10/17/2024 | 0.17 | 0.20 | 0.16 | 0.18 | 91,458,775 | |
10/16/2024 | 0.15 | 0.16 | 0.14 | 0.16 | 39,686,912 | |
10/15/2024 | 0.15 | 0.15 | 0.14 | 0.14 | 8,937,236 | |
10/14/2024 | 0.15 | 0.15 | 0.14 | 0.15 | 8,488,612 | |
10/11/2024 | 0.14 | 0.15 | 0.14 | 0.15 | 7,071,855 | |
10/10/2024 | 0.14 | 0.15 | 0.14 | 0.14 | 11,457,816 | |
10/09/2024 | 0.14 | 0.15 | 0.13 | 0.15 | 15,849,300 | |
10/08/2024 | 0.17 | 0.18 | 0.14 | 0.14 | 46,870,714 | |
10/07/2024 | 0.14 | 0.15 | 0.14 | 0.14 | 15,339,553 | |
10/04/2024 | 0.13 | 0.15 | 0.12 | 0.14 | 21,118,009 | |
10/03/2024 | 0.13 | 0.13 | 0.12 | 0.13 | 19,456,861 | |
10/02/2024 | 0.14 | 0.14 | 0.13 | 0.13 | 9,947,094 | |
10/01/2024 | 0.14 | 0.14 | 0.13 | 0.14 | 18,850,343 | |
09/30/2024 | 0.15 | 0.15 | 0.14 | 0.15 | 19,348,497 | |
09/27/2024 | 0.18 | 0.21 | 0.14 | 0.15 | 207,616,127 | |
09/26/2024 | 0.14 | 0.14 | 0.13 | 0.14 | 5,897,566 | |
09/25/2024 | 0.13 | 0.13 | 0.13 | 0.13 | 8,972,094 | |
09/24/2024 | 0.14 | 0.14 | 0.13 | 0.13 | 9,732,184 | |
09/23/2024 | 0.14 | 0.14 | 0.13 | 0.13 | 17,313,378 | |
09/20/2024 | 0.15 | 0.15 | 0.14 | 0.15 | 10,165,302 | |
09/19/2024 | 0.16 | 0.17 | 0.15 | 0.15 | 28,045,798 | |
09/18/2024 | 0.15 | 0.15 | 0.14 | 0.15 | 8,943,542 | |
09/17/2024 | 0.15 | 0.15 | 0.14 | 0.15 | 11,925,475 | |
09/16/2024 | 0.16 | 0.16 | 0.15 | 0.15 | 12,523,991 | |
09/13/2024 | 0.16 | 0.16 | 0.15 | 0.16 | 14,110,100 | |
09/12/2024 | 0.15 | 0.17 | 0.15 | 0.16 | 20,067,193 | |
09/11/2024 | 0.15 | 0.16 | 0.14 | 0.15 | 16,761,274 | |
09/10/2024 | 0.17 | 0.17 | 0.15 | 0.16 | 24,905,845 | |
09/09/2024 | 0.23 | 0.23 | 0.16 | 0.17 | 229,047,586 | |
09/06/2024 | 0.16 | 0.16 | 0.13 | 0.14 | 16,750,509 |
About Tonix Pharmaceuticals Stock history
Tonix Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Tonix is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Tonix Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Tonix Pharmaceuticals stock prices may prove useful in developing a viable investing in Tonix Pharmaceuticals
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 532.5 K | 559.1 K | |
Net Loss | -105.2 M | -99.9 M |
Tonix Pharmaceuticals Quarterly Net Working Capital |
|
Tonix Pharmaceuticals Stock Technical Analysis
Tonix Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Manager Now
Portfolio ManagerState of the art Portfolio Manager to monitor and improve performance of your invested capital |
All Next | Launch Module |
Tonix Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Tonix Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Tonix Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Tonix to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.03) | |||
Jensen Alpha | (0.80) | |||
Total Risk Alpha | (1.72) | |||
Treynor Ratio | (0.12) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Tonix Stock Analysis
When running Tonix Pharmaceuticals' price analysis, check to measure Tonix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tonix Pharmaceuticals is operating at the current time. Most of Tonix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tonix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tonix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tonix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.